BioSpace News Archive

The global hospital gowns market is growing due to the ever increasing number of surgeries and other medical procedures.

Lipidor AB announced an agreement with Cadila Pharmaceuticals, a leading Indian pharmaceutical company with extensive CRO capacity, to conduct a Phase III study for Lipidor’s drug candidate AKP-02.

Cyxone, a Swedish biotech in autoimmune diseases, announces that the company has engaged Professor Rikard Holmdahl as Senior Scientific Advisor for the company’s projects in autoimmune diseases.

Company Secures EUR 17.5M from European Innovation Council and EUR 15.1M from Bpifrance as part of PSCP COVID-19

NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that the Company will release second quarter 2020 financial results after the close of the market on Monday, August 10, 2020.

Merck, known as MSD outside the United States and Canada, and Eisai announced that the U.S. Food and Drug Administration has issued a Complete Response Letter regarding Merck’s and Eisai’s applications seeking accelerated approval of KEYTRUDA, Merck’s anti-PD-1 therapy, plus LENVIMA, the orally available multiple receptor tyrosine kinase inhibitor discovered by Eisai, for the first-line treatment of patients with unresectable hepatocellular carcinoma.

Company Finalizes Initial Pandemic Order for 50 Million Injection Devices to Support Operation Warp Speed Vaccination Program

RGX-111 and RGX-121 continue to be well-tolerated in patients with MPS I and MPS II following one-time intracisternal administration

Concert Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration granted Breakthrough Therapy Designation for the Company’s oral Janus kinase inhibitor, CTP-543, for the treatment of adult patients with moderate-to-severe alopecia areata.

Mevion Medical Systems announced that patient treatment has commenced on the MEVION S250i Proton Therapy System® at the S. Lee Kling Proton Therapy Center at Siteman Cancer Center, based at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis.